Clinical evaluation of the Frax 1940™ non-ablative fractional diode laser for skin resurfacing and treatment of benign pigmented lesions
Introducing a new indication for the Frax 1940™
The Frax 1940 is now FDA-cleared for treatment of benign pigmented lesions!
Available on the Nordlys™ and Frax Pro® systems, you can now offer patients a way to enjoy smoother skin and get clearance of their dark spots in a single treatment!
Read about the immediate and glowing Frax 1940 treatment results for both epidermal skin resurfacing and pigmentation. Download the Frax 1940 clinical results white paper and learn how you can expand your practice offerings with targeted epidermal treatments, the latest in non-ablative technology.